Prevalence of thyroid function test abnormalities and anti-thyroid antibodies an open population in central México

Revista de Investigacion Clinica

Volumn 66, Issue 2, 2014, Pages 113-120

  Robles Osorio, Ma Ludivina ^a   Zacarías Rangel, Verónica ^c   García Solís, Pablo ^a   Hernández Montiel, Hebert Luis ^a   Solís, Juan Carlos ^a   Sabath, Ernesto ^b  

^a UNIVERSIDAD AUTÓNOMA DE QUERÉTARO   (Mexico)

^b SESEQ   (Mexico)

^c Hospital Angeles Queretaro   (Mexico)

Author keywords

Anti thyroid antibodies; Hyperthyroidism; Hypothyroidism; Thyroid disease

Indexed keywords

LEVOTHYROXINE; RADIOACTIVE IODINE; THYROGLOBULIN ANTIBODY; THYROID PEROXIDASE ANTIBODY; THYROTROPIN; THYROXINE; AUTOANTIBODY;

ADULT; AGE DISTRIBUTION; AGED; ARTICLE; BLOOD SAMPLING; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; FEMALE; GRAVES DISEASE; HUMAN; HYPERTHYROIDISM; HYPOTHYROIDISM; MAJOR CLINICAL STUDY; MALE; MEXICO; POPULATION; PREVALENCE; QUALITY OF LIFE; SUBCLINICAL HYPERTHYROIDISM; SUBCLINICAL HYPOTHYROIDISM; THYROID DISEASE; THYROID FUNCTION TEST; THYROTROPIN BLOOD LEVEL; THYROXINE BLOOD LEVEL; BLOOD; EPIDEMIOLOGY; IMMUNOLOGY; THYROID DISEASES; THYROID GLAND;

ADULT; AUTOANTIBODIES; CROSS-SECTIONAL STUDIES; FEMALE; HUMANS; MALE; MEXICO; PREVALENCE; THYROID DISEASES; THYROID FUNCTION TESTS; THYROID GLAND; THYROTROPIN; THYROXINE;

EID: 84908222322     PISSN: 00348376     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (29)

1. Tunbridge WM, Evered DC, Hall R, Appleton D, Brewis M, Clark F, et al. The spectrum of thyroid disease in a community: The Whickham survey. Clin Endocrinol (Oxf) 1977; 7: 481-93.
2. Hollowell JG, Staehling NW, Flanders WD, et al. Serum TSH, T(4), and thyroid antibodies in the United States population (1988 to 1994): National Health and Nutrition Examination Survey (NHANESIII). J Clin Endocrinol Metab 2002; 87: 489-99.
3. Canaris GJ, Manowitz NR, Mayor G, Ridgway EC. The Colorado thyroid disease prevalence study. Arch Intern Med 2000; 160: 526-34.
4. Takeda K, Mishiba M, Sugiura H, Nakajima A, Kohama M, Hi- ramatsu S. Evaluated reference intervals for serum free thyroxine and thyrotropin using the conventional outliner rejection test without regard to presence of thyroid antibodies and prevalence of thyroid dysfunction in Japanese subjects. Endocr J 2009; 56: 1059-66.
5. Londono AL, Gallego ML, Bayona A, Landazuri P. Prevalen- cia de hipotiroidismo y relacion con niveles elevados de anti- cuerpos antiperoxidasa y yoduria en poblacion de 35 y mas afios en Armenia 2009-2010. Rev Salud Publico 2011; 13: 998-1013.
6. Garduno-Garcfa JJ, Alvirde-Garcfa U, López-Carrasco G, Padilla-Mendoza ME, Mehta R, et al. TSH and free thyroxine con-centrations are associated with fdifering metabolic markers in euthyroid subjects. Eur J Endocrinol 2011; 163: 273-8.
7. Rodondi N, den-Elzen WP, Bauer DC, Cappola AR, Razvi S, et al. Subclinical hypothyroidism and the risk of coronary heart disease and mortality. JAMA 2010; 304: 1365-74.
8. Gencer B, Collet TH, Virgini V, Bauer DC, Gussekloo J, et al. Subclinical thyroid dysfunction and the risk of heart failure events. An individual participant data analysis from 6 prospective cohorts. Circulation 2012; 120: 1040-9.
9. Shin DH, Lee MJ, Kim SJ, Oh HJ, Han JH, et al. Preservation of renal function by thyroid hormone replacement therapy in chronic kidney disease patients with subclinical hypothyroidism. J Clin Endocrinol Metab 2012; 97: 2732-40.
10. Gussekloo J, van Exel E, de Craen AJM, Meinders AE, Frölich M, et al. Thyroid status, disability and cognitive function, and survival in old age. JAMA 2004; 292: 2591-9.
11. Surks MI, Ortiz E, Daniels GH, Sawin CT, Col NF, Cobin RH, et al. Subclinical thyroid disease: scientific review and guidelines for diagnosis and management. JAMA 2004; 291: 228-38.
12. Bauer DC, Ettinger B, Nevitt MC, Stone KL. Study of osteopo-rotic fractures research group, risk for fracture in women with low serum levels of thyroid-stimulating hormone. Ann Intern Med 2001; 134: 561-8.
13. Lee JS, Buzkova P, Fink HA, Vu J, Carbone L, et al. Subclinical thyroid dysfunction and incident hip fracture in older adults. Arch Intern Med 2010; 170: 1876-83.
14. Selmer C, Bjerring-Olesen J, Lock-Hansen M, Lindhardsen J, Schjerning-Olsen AM, et al. The spectrum of thyroid disease and risk of new onset atrial fibrillation: A large population cohort study. BMJ 2012; 345: e7895.
15. Benseftor IM, Lotufo PA, Menezes PR, Scazufca M. Subclinical hyperthyroidism and dementia: The Sao Paulo Ageing and Health Study (SPAH). BMC Public Health 2010; 10: 298.
16. Zulewski H, Müller B, Exer P, Miserez, A, Staub JJ. Estimation of tissue hypothyroidism by a new clinical score: Evaluation of patients with various grades of hypothyroidism and controls. J Clin Endocrinol Metab 1997; 82: 771-6.
17. Rosario PW, Xavier AC, Calsolari MR. TSH reference values for adult Brazilian population. Arq Bras Endocrinol Metabol 2010; 54: 603-06.
18. Hurtado-López LM, Basurto-Kuba E, Montes de Ocadurin ER, Pulido-Cejudo A, VSzquez-Ortega C, et al. Prevalencia de nódu- lo tiroideo en el valle de Mexico. Cir Cir 2011; 79: 114-7.
19. Ladenson PW, Singer PA, Ain KB, Bagchi N, Bigos T, et al. American Thyroid Association guidelines for detection of thyroid dysfunction. Arch Intern Med 2000; 160: 1573-5.
20. Garber JR, Cobin RH, Gharib H, Hennessey JV, Klein I, et al. Clinical practice guidelines for hypothyroidism in adults: cosponsored by the American Association of Clinical Endocrinologist and the American Thyroid Association. Endocr Pract 2012; 18: 988-1028.
21. Cooper DS. Subclinical hypothyroidism. N Engl J Med 2001; 345: 260-5.
22. Fatourechi V. Upper Limit of Normal Serum Thyroid-Stimula- ting Hormone: A Moving and Now an Aging Target? J Clin Endocrinol Metab 2007; 92: 1460-2.
23. Razvi S, Ingoe L, Keeka G, Oates C, McMillan C, Weaver JU. The beneficial effect of 1-Thyroxine on cardiovascular risk factors, endothelial function, and quality of life in subclinical hypothyroidism: randomized, crossover trial. J Clin Endocrinol Metab 2007; 92: 1715-23.
24. Villar HC, Saconato H, Valente O, Atallah AN. Thyroid hormone replacement for subclinical hypothyroidism. Cochrane Database Syst Rev 2007; 18: CD003419.
25. Shin DH, Lee MJ, Lee HS, Oh HJ, Kim CH, et al. Thyroid hor-mone replacement therapy attenuates the decline of renal function in chronic kidney disease patients with subclinical hypothyroidism. Thyroid 2013; 23: 654-61.
26. Strieder TG, Tijssen J, Wenzel BE, Endert E, Wiersinga WM. Prediction of progression to overt hypothyroidism in female relatives of patients with autoimmune thyroid disease using the thyroid events Amsterdam (THEA) score. Arch Intern Med 2008; 168: 1657-63.
27. Tozzoli R, Bizarro N, Tonutti E, Pradella M, Manoni F, et al. Immunoassay of anti-thyroid autoantibodies: high analytical variability in second generation methods. Clin Chem Lab Med 2002; 40: 568-73.
28. Bjøro T, Holmen J, Krtiger O, Midthjell K, Hunstad K, Schreiner T, Sandnes L, et al. Prevalence of thyroid disease, thyroid dysfunction and thyroid peroxidase antibodies in a large, unse- lected population. The Health Study of Nord-Trondelag (HUNT). Eur J Endocrinol 2000; 143: 639-47.
29. Palacios SS, Larumbe AB, Guilten-Grima F, GaloW JC. A cross-sectional study of the association between circulating TSH level and lipid profile in a large Spanish population. Clin Endocrinol (Oxf) 2013 [Epub ahead of print].